AstraZeneca PLC (AZN)

NYSE

$162,54

$+4,36

(+2,75%)

Pre-Market

AstraZeneca PLC (AZN) Live Price Chart

Last updated: ⁦2026-10-13 09:55:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

AstraZeneca PLC (AZN) operates in the -- sector and is listed on NYSE. The stock is currently priced at $162,54, with a market capitalization of $246,90B and a P/E ratio of 110,56. Over the past 52 weeks, its price has ranged from $153,41 to $212,71. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$246,90B
Open	$159,47
Day's High	$212,71
Day's Low	$29,96
Previous Close	$158,33
Volume	17,40K
Average Volume	3,31M
P/E Ratio	110,56
52-Week High	$212,71
52-Week Low	$153,41
Dividend Yield	1,44%
Earnings Date	--

AstraZeneca PLC (AZN) Pre-Market Stock Price

AstraZeneca PLC (AZN) is trading at $162,54 in pre-market trading as of 2026-10-13 09:53:00, up 2,66% ($4,21) from the previous close of $158,33

Pre-market trading shows how investors are pricing AZN before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

AstraZeneca PLC (AZN) 7-Day Stock Price Change

Over the past seven days, AstraZeneca PLC (AZN) moved from $156,90 to $162,54, representing a gain of 3,59% ($5,64).

The stock traded between $154,81 and $162,89 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 2,61 million shares, down versus the previous seven-day period, indicating lower trading activity.

AZN 52-Week Price Position

Position in Range: 15,4%

52W Low$153,41

52W High$212,71

AZN is currently trading at $162,54, placing it 15,4% of the way from its 52-week low of $153,41 to its 52-week high of $212,71. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is AstraZeneca PLC (AZN)?

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

AstraZeneca PLC Information

Employees	96100
Exchange	NYSE
Company Website	https://www.astrazeneca.com

How to Buy AstraZeneca PLC (AZN) Stock on MEXC

Eligible investors can buy real shares of AstraZeneca PLC (AZN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AZN and Place Your Order

Open the RealStocks trading page and search for AZN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is AstraZeneca PLC (AZN) stock price today?

AstraZeneca PLC (AZN) is currently trading at $ 162,54, up 2,66% ($4,21) from the previous close of $ 158,33. Intraday prices update in real time during regular trading hours.

2.Is AZN stock going up or down today?

As of 2026-10-13 09:53:00, AZN is trading at $ 162,54, up 2,66% ($4,21) from its previous close of $ 158,33. The stock has traded between $ 29,96 and $ 212,71 during today’s regular session. Past price movements do not guarantee future results.

3.What is AZN pre-market price?

As of 2026-10-13 09:53:00, AZN is trading at $ 162,54 in pre-market trading, up 2,66% ($4,21) from the previous close of $ 158,33. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AZN after-hours price?

As of 2026-10-13 09:53:00, AZN is trading at $ 158,88 in after-hours trading, up 0,34% ($0,54) from the regular-session close of $ 158,33. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AZN stock trading now?

AZN trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AZN sit relative to its 52-week high and low?

Over the past 52 weeks, AZN has traded between a low of $ 153,41 and a high of $ 212,71. At $ 162,54, the stock is positioned 15,4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is AstraZeneca PLC in?

AstraZeneca PLC (AZN) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is AstraZeneca PLC's market capitalization and where is it listed?

AstraZeneca PLC is listed on the NYSE exchange with a market capitalization of $ 246,90B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AZN valued in terms of P/E ratio and EPS?

AZN trades at a P/E ratio of 110,56, based on trailing-twelve-month EPS of $ 1,43. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does AstraZeneca PLC pay a dividend?

AstraZeneca PLC pays an indicated annual cash dividend of $ 2,34 per share, with a current dividend yield of 1,44% based on the latest share price. Dividend policies are subject to change at the board's discretion.